Hybrigenics Société Anonyme
Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, Fr… Read more
Market Cap & Net Worth: Hybrigenics Société Anonyme (3HB)
Hybrigenics Société Anonyme (STU:3HB) has a market capitalization of $850.04K (€828.12K) as of March 18, 2026. Listed on the STU stock exchange, this Germany-based company holds position #38310 globally and #5154 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hybrigenics Société Anonyme's stock price €0.00 by its total outstanding shares 828118245 (828.12 Million).
Hybrigenics Société Anonyme Market Cap History: 2015 to 2026
Hybrigenics Société Anonyme's market capitalization history from 2015 to 2026. Data shows change from $908.69 Million to $850.04K (-49.36% CAGR).
Hybrigenics Société Anonyme Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hybrigenics Société Anonyme's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.51x
Hybrigenics Société Anonyme's market cap is 6.51 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $688.36 Million | $3.61 Million | -$5.26 Million | 190.89x | N/A |
| 2017 | $522.77 Million | $1.88 Million | -$7.96 Million | 278.07x | N/A |
| 2018 | $59.50 Million | $76.73K | -$7.53 Million | 775.47x | N/A |
| 2019 | $79.05 Million | $234.93K | -$735.51K | 336.51x | N/A |
| 2020 | $176.81 Million | $150.62K | -$326.68K | 1173.86x | N/A |
| 2021 | $106.26 Million | $147.13K | -$69.16K | 722.18x | N/A |
| 2022 | $47.94 Million | $1.56K | -$563.57K | 30634.05x | N/A |
| 2023 | $15.30 Million | $612.00K | -$7.87 Million | 25.00x | N/A |
| 2024 | $4.00 Million | $614.00K | -$1.10 Million | 6.51x | N/A |
Competitor Companies of 3HB by Market Capitalization
Companies near Hybrigenics Société Anonyme in the global market cap rankings as of March 18, 2026.
Key companies related to Hybrigenics Société Anonyme by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Hybrigenics Société Anonyme Historical Marketcap From 2015 to 2026
Between 2015 and today, Hybrigenics Société Anonyme's market cap moved from $908.69 Million to $ 850.04K, with a yearly change of -49.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €850.04K | -76.19% |
| 2025 | €3.57 Million | -10.64% |
| 2024 | €4.00 Million | -73.89% |
| 2023 | €15.30 Million | -68.09% |
| 2022 | €47.94 Million | -54.88% |
| 2021 | €106.26 Million | -39.90% |
| 2020 | €176.81 Million | +123.66% |
| 2019 | €79.05 Million | +32.86% |
| 2018 | €59.50 Million | -88.62% |
| 2017 | €522.77 Million | -24.06% |
| 2016 | €688.36 Million | -24.25% |
| 2015 | €908.69 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Hybrigenics Société Anonyme was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $850.04K USD |
| MoneyControl | $850.04K USD |
| MarketWatch | $850.04K USD |
| marketcap.company | $850.04K USD |
| Reuters | $850.04K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.